Gfin Capital Limited
Founded: 2003
Status: Strike Off
Designation: Director
SM
Sekaripuram Anantaraman Manikandan, Director and Managing Director, with 12 companies.
Sekaripuram Anantaraman Manikandan has 29 years in corporate governance. Holds Director and Managing Director roles. Currently with 6 companies, including Gfin Capital Limited and Verza Ventures & Investments Private Limited. Formerly with 6 companies, such as Grandix Pharmaceuticals Limited and Grandix Pharmaceuticals Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Founded: 2003
Status: Strike Off
Designation: Director
Founded: 2010
Status: Strike Off
Designation: Director
Founded: 2012
Status: Strike Off
Designation: Managing Director
Founded: 2012
Status: Strike Off
Designation: Director
Founded: 2025
Status: Active
Designation: Managing Director
Founded: 2025
Status: Active
Designation: Director
Founded: 1996
Status: Amalgamated
Designation: Director
Founded: 1996
Status: Amalgamated
Designation: Managing Director
Founded: 2010
Status: Under Liquidation
Designation: Managing Director
Founded: 2015
Status: Active
Designation: Additional Director
Founded: 2012
Status: Strike Off
Designation: Director
Founded: 2001
Status: Amalgamated
Designation: Whole-Time Director
Explore Director's current and past company associations— Uncover their professional journey today!
Sekaripuram Anantaraman Manikandan has 29 years in corporate governance. Holds Director and Managing Director roles. Currently with 6 companies, including Gfin Capital Limited and Verza Ventures & Investments Private Limited. Formerly with 6 companies, such as Grandix Pharmaceuticals Limited and Grandix Pharmaceuticals Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Sekaripuram Anantaraman Manikandan is associated with 6 companies as Director and Managing Director.
Sekaripuram Anantaraman Manikandan has expertise in General Business, Healthcare.
Sekaripuram Anantaraman Manikandan has 29 years in corporate governance.